PTHS · Pelthos Therapeutics Inc.

Pelthos Therapeutics has appointed John M. Gay as its new Chief Financial Officer, Treasurer, and Secretary, effective April 10, 2026, marking a leadership transition in its financial operations. Mr. Gay, who joined the company in July 2025 as Senior Vice President, Finance & Accounting, brings over 25 years of public company finance experience, including prior roles as CFO at LNHC, Inc. and Novan, Inc. His appointment follows the termination of Francis Knuettel II, whose departure was not due to any disagreement with the company. The employment agreement for Mr. Gay includes a competitive compensation package with a $425,000 annual base salary and a target annual bonus of 40% of base salary, aligning his incentives with company performance. This change in financial leadership occurs as Pelthos continues its commercial momentum and growth phase, with CEO Scott Plesha noting Mr. Gay's key role in establishing the company. The company expects to finalize separation terms with Mr. Knuettel under his existing agreement, with details to be disclosed in a future filing if required.